Free Daily Podcast Summary
The GLP-1 Podcast Show: Daily Summaries Delivered
by Wisenetix
A whole new era of communication in GLP-1 is here! Now you’ve got the sharpest minds in GLP-1 research right in your pocket. What’s best? You can listen to them while driving to the hospital, walking between labs, traveling, or just running errands. It’s never been this good or this simple. Welcome to The GLP-1 Podcast Show, a monthly podcast where you’ll hear cutting-edge perspectives and what’s working in the world of GLP-1. Our aspiration is to be the first place you are going to go to find out what's happening, the latest breakthroughs, clinical updates, and innovations in GLP-1 care and research.
Latest Episodes
The most recent episodes — sign up to get AI-powered summaries of each one.
- 1 weeks ago43 min
Dr. Ian Justl Ellis: Personalizing GLP-1 Dosing | Ep. 17
In this episode of The GLP-1 Podcast Show, I speak with Dr. Ian Justl Ellis, a board-certified physician and founder of Voafit, about personalized GLP-1 treatment. Drawing on his experience as both a patient and physician, he explains how medication levels change as weekly doses accumulate, why individual responses can vary, and how gradual adjustments guided by appetite, side effects, nutrition, and objective progress support more personalized care. We also discuss patient monitoring, dose delivery challenges, and the clinical research needed to evaluate this approach at scale. Listen now on all major platforms. "The goal is a felt experience that is positive, that is resulting in objective changes." Meet the guest: Dr. Ian Justl Ellis https://www.linkedin.com/in/voafitmd is a board-certified physician and founder and CEO of Voafit. His work focuses on personalized GLP-1 care, precision dosing, and technology that supports individualized medication management. With a background in emergency medicine, fitness, and medical education, Dr. Ellis brings a multidisciplinary perspective to obesity care. Listen to Dr. Ian Justl Ellis on The GLP-1 Podcast Show, available on all major platforms. Want to stay up to date on the latest GLP-1 research and updates? Subscribe and never miss an episode: https://glp1podcast.com/ Liked this one? Don’t stop now. Here’s what we think you’ll love: https://www.wisenetix.co/blog?tag=the+glp-1+podcast+show What you will learn: Highlight Introduction Personal experience with obesity Starting semaglutide Precision dosing A personalized dosing model Dose delivery challenges Closing thoughts The GLP-1 Podcast Show is trusted and supported by innovative companies like: - WiseVAs (https://www.wisevas.io/) - ZentrixOS (https://zentrixos.com/) - Zentrix Insights (https://zentrixinsights.com/) 𝗟𝗶𝘀𝘁𝗲𝗻 𝗼𝗻 𝗔𝗽𝗽𝗹𝗲 𝗣𝗼𝗱𝗰𝗮𝘀𝘁𝘀, 𝗦𝗽𝗼𝘁𝗶𝗳𝘆 𝗼𝗿 𝗮𝗻𝘆 𝗺𝗮𝗷𝗼𝗿 𝗽𝗹𝗮𝘁𝗳𝗼𝗿𝗺. Website: https://theglp1podcast.com/ LinkedIn: https://www.linkedin.com/showcase/the-glp-1-podcast-show/ Instagram: https://www.instagram.com/theglp1podcast/ Facebook: https://www.facebook.com/profile.php?id=61577863745840 TikTok: https://www.tiktok.com/@theglp1podcast
- 3 weeks ago27 min
Dr. Anders Fink-Jensen: GLP-1 Therapy for Alcohol Use Disorder | Ep. 16
In this episode of The GLP-1 Podcast Show, I speak with Dr. Anders Fink-Jensen, Professor of Psychiatry at the University of Copenhagen and a consultant psychiatrist, about the emerging role of GLP-1 receptor agonists in addiction treatment. We examine the clinical observations that initiated this research, findings from a randomized trial of semaglutide for alcohol use disorder, possible effects on craving, dosing considerations, and the evidence still needed before broader clinical use. Listen now on all major platforms. "Semaglutide reduced both total alcohol consumption and the number of heavy drinking days." Meet the guest: Dr. Anders Fink-Jensen https://www.linkedin.com/in/anders-fink-jensen-b7a4a022 is a professor at the University of Copenhagen and a consultant psychiatrist. His research focuses on psychopharmacology, addiction, severe mental illness, and the clinical evaluation of GLP-1 receptor agonists in people with alcohol use disorder. Listen to Dr. Anders Fink-Jensen on The GLP-1 Podcast Show, available on all major platforms. Want to stay up to date on the latest GLP-1 research and updates? Subscribe and never miss an episode: https://glp1podcast.com/ Liked this one? Don’t stop now. Here’s what we think you’ll love: https://www.wisenetix.co/blog?tag=the+glp-1+podcast+show What you will learn: Highlight Introduction Origins of addiction research Semaglutide trial design Alcohol use outcomes Patient selection Future clinical research Closing thoughts The GLP-1 Podcast Show is trusted and supported by innovative companies like: - ZentrixOS (https://zentrixos.com/) - Zentrix Insights (https://zentrixinsights.com/) - Elevate (https://elevateagents.ai/) - WiseVAs (https://www.wisevas.io/) 𝗟𝗶𝘀𝘁𝗲𝗻 𝗼𝗻 𝗔𝗽𝗽𝗹𝗲 𝗣𝗼𝗱𝗰𝗮𝘀𝘁𝘀, 𝗦𝗽𝗼𝘁𝗶𝗳𝘆 𝗼𝗿 𝗮𝗻𝘆 𝗺𝗮𝗷𝗼𝗿 𝗽𝗹𝗮𝘁𝗳𝗼𝗿𝗺. Website: https://theglp1podcast.com/ LinkedIn: https://www.linkedin.com/showcase/the-glp-1-podcast-show/ Instagram: https://www.instagram.com/theglp1podcast/ Facebook: https://www.facebook.com/profile.php?id=61577863745840 TikTok: https://www.tiktok.com/@theglp1podcast
- Oct 5, 202631 min
Dr. Michelle Gordon: GLP-1 Care for Women in Midlife | Ep. 15
In this episode of The GLP-1 Podcast Show, I speak with Dr. Michelle Gordon, a physician board-certified in obesity medicine and CEO of Thrive Span Medical, about obesity care for women in midlife. We discuss how GLP-1 therapy fits into long-term disease management, why slower weight reduction, adequate protein, resistance training, hydration, and fiber matter, and how hormonal changes may affect weight, cognition, and metabolic health. Dr. Gordon also explains when bariatric surgery remains appropriate and why obesity should be treated as a complex chronic disease. Listen now on all major platforms. "You need the amount of protein to also fuel your muscles, but it has to be coupled with resistance training." Meet the guest: Dr. Michelle Gordon https://www.linkedin.com/in/drmichellegordon is a physician board-certified in obesity medicine, lifestyle medicine, and general surgery. She is CEO of Thrive Span Medical, a physician-led telehealth clinic focused on midlife weight gain, menopause, and chronic disease. Her clinical work combines obesity medicine, hormone replacement when indicated, evidence-based lifestyle interventions, and personalized long-term care. Listen to Dr. Michelle Gordon on The GLP-1 Podcast Show, available on all major platforms. Want to stay up to date on the latest GLP-1 research and updates? Subscribe and never miss an episode: https://glp1podcast.com/ Liked this one? Don’t stop now. Here’s what we think you’ll love: https://www.wisenetix.co/blog?tag=the+glp-1+podcast+show What you will learn: Highlight Introduction Gaps in women’s health research Muscle preservation during weight loss Estrogen and cognitive changes Midlife metabolism Long-term therapy Closing thoughts The GLP-1 Podcast Show is trusted and supported by innovative companies like: - Elevate (https://elevateagents.ai/) - WiseVAs (https://www.wisevas.io/) - ZentrixOS (https://zentrixos.com/) - Zentrix Insights (https://zentrixinsights.com/) 𝗟𝗶𝘀𝘁𝗲𝗻 𝗼𝗻 𝗔𝗽𝗽𝗹𝗲 𝗣𝗼𝗱𝗰𝗮𝘀𝘁𝘀, 𝗦𝗽𝗼𝘁𝗶𝗳𝘆 𝗼𝗿 𝗮𝗻𝘆 𝗺𝗮𝗷𝗼𝗿 𝗽𝗹𝗮𝘁𝗳𝗼𝗿𝗺. Website: https://theglp1podcast.com/ LinkedIn: https://www.linkedin.com/showcase/the-glp-1-podcast-show/ Instagram: https://www.instagram.com/theglp1podcast/ Facebook: https://www.facebook.com/profile.php?id=61577863745840 TikTok: https://www.tiktok.com/@theglp1podcast
- Sep 21, 202627 min
Dr. Jon Campbell: Understanding GIP and Glucagon | Ep. 14
In this episode of The GLP-1 Podcast Show, I speak with Dr. Jon Campbell, Associate Professor of Medicine at Duke University, about the changing science of GIP and glucagon. We examine GIP physiology, glucagon signaling, weight-independent metabolic effects, multi-receptor agonism, and variability in treatment response. Discover how emerging pharmacology could shape more precise obesity treatment. Listen now on all major platforms. "GI think it’s going to take a little while, but people are going to come around to this idea that glucagon, particularly when combined with an incretin like GIP or GLP-1, is a really powerful way to improve metabolic disease." Meet the guest: Dr. Jon Campbell is an Associate Professor of Medicine at Duke University. His research examines incretin hormones, pancreatic islet biology, and the cellular mechanisms that regulate glucose metabolism. His work has helped advance understanding of GIP, GLP-1, glucagon, and the signaling pathways that may shape future metabolic therapies. Listen to Dr. Jon Campbell on The GLP-1 Podcast Show, available on all major platforms. What you will learn: Highlight Introduction GIP biology Hormone contributions Optimized agonists Glucagon actions Multi-hormone therapies Closing thoughts The GLP-1 Podcast Show is trusted and supported by innovative companies like: - Zentrix Insights (https://zentrixinsights.com/) - ZentrixOS (https://zentrixos.com/) - WiseVAs (https://www.wisevas.io/) - Elevate (https://elevateagents.ai/) 𝗟𝗶𝘀𝘁𝗲𝗻 𝗼𝗻 𝗔𝗽𝗽𝗹𝗲 𝗣𝗼𝗱𝗰𝗮𝘀𝘁𝘀, 𝗦𝗽𝗼𝘁𝗶𝗳𝘆 𝗼𝗿 𝗮𝗻𝘆 𝗺𝗮𝗷𝗼𝗿 𝗽𝗹𝗮𝘁𝗳𝗼𝗿𝗺. Website: https://theglp1podcast.com/ LinkedIn: https://www.linkedin.com/showcase/the-glp-1-podcast-show/ Instagram: https://www.instagram.com/theglp1podcast/ Facebook: https://www.facebook.com/profile.php?id=61577863745840 TikTok: https://www.tiktok.com/@theglp1podcast
- Sep 7, 202635 min
Dr. Ashley Koff: Weight Health in the GLP-1 Era | Ep. 13
In this episode of The GLP-1 Podcast Show, I speak with Dr. Ashley Koff, registered dietitian, founder of The Better Nutrition Program, and bestselling author of Your Best Shot, about weight health in the GLP-1 era. She explains why body composition matters more than total weight, how digestion and hydration shape nutrition outcomes, why protein advice must be personalized, and how clinicians can support more sustainable metabolic health. Listen now on all major platforms. "Weight composition, including the type, amount, and location of bone, muscle, fat, and water, provides a more meaningful signal about health than total weight alone." Meet the guest: Dr. Ashley Koff https://www.linkedin.com/in/ashley-koff is a registered dietitian, founder of The Better Nutrition Program, and bestselling author of Your Best Shot: The Personalized System for Optimal Weight Health. She also serves as Nutrition Course Director for the Integrative and Functional Medicine Fellowship at the Susan Samueli Integrative Health Institute. Her work focuses on personalized nutrition, weight health optimization, metabolic health, practitioner education, and helping patients make better, sustainable choices. Listen to Dr. Ashley Koff on The GLP-1 Podcast Show, available on all major platforms. What you will learn: Highlight Introduction Weight health Success markers Tracking trends Functional status Nutrition priorities Future care The GLP-1 Podcast Show is trusted and supported by innovative companies like: - WiseVAs (https://www.wisevas.io/) - Elevate (https://elevateagents.ai/) - Zentrix Insights (https://zentrixinsights.com/) - ZentrixOS (https://zentrixos.com/) 𝗟𝗶𝘀𝘁𝗲𝗻 𝗼𝗻 𝗔𝗽𝗽𝗹𝗲 𝗣𝗼𝗱𝗰𝗮𝘀𝘁𝘀, 𝗦𝗽𝗼𝘁𝗶𝗳𝘆 𝗼𝗿 𝗮𝗻𝘆 𝗺𝗮𝗷𝗼𝗿 𝗽𝗹𝗮𝘁𝗳𝗼𝗿𝗺. Website: https://theglp1podcast.com/ LinkedIn: https://www.linkedin.com/showcase/the-glp-1-podcast-show/ Instagram: https://www.instagram.com/theglp1podcast/ Facebook: https://www.facebook.com/profile.php?id=61577863745840 TikTok: https://www.tiktok.com/@theglp1podcast
- Aug 24, 202633 min
Dr. Timothy Garvey: Adiposity-Based Chronic Disease Explained | Ep. 12
In this episode of The GLP-1 Podcast Show, I speak with Dr. Timothy Garvey, Endowed Professor of Medicine at the University of Alabama at Birmingham, about complication-centric care for Adiposity-Based Chronic Disease. We examine current obesity guidelines, medication selection according to complications, what the key unmet clinical need is in obesity care, and the role of second-generation GLP-1 medications in type 2 diabetes. Listen now on all major platforms. "Obesity treatment should focus on improving complications, quality of life, and health, not simply reaching a target amount of weight loss." Meet the guest: Dr. Timothy Garvey https://scholars.uab.edu/1853-w-timothy-garvey is Endowed Professor and University Professor of Medicine at the University of Alabama at Birmingham. An endocrinologist specializing in obesity and type 2 diabetes, he has authored more than 380 publications and helped establish Adiposity-Based Chronic Disease as a diagnostic framework while leading major obesity guidelines. Listen to Dr. W. Timothy Garvey on The GLP-1 Podcast Show, available on all major platforms. What you will learn: Highlight Introduction Clinical guidelines Complication care Medication selection Disease evidence Diabetes management Closing thoughts The GLP-1 Podcast Show is trusted and supported by innovative companies like: - ZentrixOS (https://zentrixos.com/) - Zentrix Insights (https://zentrixinsights.com/) - Elevate (https://elevateagents.ai/) - WiseVAs (https://www.wisevas.io/) 𝗟𝗶𝘀𝘁𝗲𝗻 𝗼𝗻 𝗔𝗽𝗽𝗹𝗲 𝗣𝗼𝗱𝗰𝗮𝘀𝘁𝘀, 𝗦𝗽𝗼𝘁𝗶𝗳𝘆 𝗼𝗿 𝗮𝗻𝘆 𝗺𝗮𝗷𝗼𝗿 𝗽𝗹𝗮𝘁𝗳𝗼𝗿𝗺. Website: https://theglp1podcast.com/ LinkedIn: https://www.linkedin.com/showcase/the-glp-1-podcast-show/ Instagram: https://www.instagram.com/theglp1podcast/ Facebook: https://www.facebook.com/profile.php?id=61577863745840 TikTok: https://www.tiktok.com/@theglp1podcast
- Aug 3, 202632 min
Dr. Christopher Kramer: Tirzepatide And Cardiovascular Health | Ep. 11
In this episode of The GLP-1 Podcast Show, I speak with Dr. Christopher Kramer, Chief of the Cardiovascular Division at the University of Virginia Health, about how GLP-1 and GIP therapies are reshaping the treatment of obesity-related heart failure. We explore cardiac remodeling, adipose tissue reduction, cardiovascular outcomes, and the mechanisms behind improved patient health. Listen now on all major platforms! "Treatment with tirzepatide reduced heart failure events by approximately fifty percent while helping patients feel better and perform daily activities more comfortably." Meet the guest: Dr. Christopher Kramer https://www.linkedin.com/in/christopher-kramer-55200931/ earned his A.B. from Harvard and his M.D. from UCSF before completing cardiology training at the University of Pennsylvania. He is the George A. Beller, MD/Lantheus Medical Imaging Distinguished Professor of Cardiovascular Medicine and Chief of the Cardiovascular Division at the University of Virginia Health. His research focuses on cardiovascular magnetic resonance imaging and heart disease. Listen to Dr. Christopher Kramer on The GLP-1 Podcast Show, available on all major platforms. What you will learn: Highlight Introduction Heart failure outcomes Cardiac adipose reduction Ventricular remodeling Weight loss benefits Future triple agonists Final Questions The GLP-1 Podcast Show is trusted and supported by innovative companies like: - Elevate (https://elevateagents.ai/) - WiseVAs (https://www.wisevas.io/) - ZentrixOS (https://zentrixos.com/) - Zentrix Insights (https://zentrixinsights.com/) 𝗟𝗶𝘀𝘁𝗲𝗻 𝗼𝗻 𝗔𝗽𝗽𝗹𝗲 𝗣𝗼𝗱𝗰𝗮𝘀𝘁𝘀, 𝗦𝗽𝗼𝘁𝗶𝗳𝘆 𝗼𝗿 𝗮𝗻𝘆 𝗺𝗮𝗷𝗼𝗿 𝗽𝗹𝗮𝘁𝗳𝗼𝗿𝗺. Website: https://theglp1podcast.com/ LinkedIn: https://www.linkedin.com/showcase/the-glp-1-podcast-show/ Instagram: https://www.instagram.com/theglp1podcast/ Facebook: https://www.facebook.com/profile.php?id=61577863745840 TikTok: https://www.tiktok.com/@theglp1podcast
- Jul 6, 202633 min
Dr. Richard DiMarchi: The Evolution of GLP-1 Science | Ep. 10
In this episode of The GLP-1 Podcast Show, I speak with Dr. Richard DiMarchi, Distinguished Professor at Indiana University and a pioneer in peptide therapeutics, about the scientific journey behind GLP-1 therapies, multiagonist drug development, and future obesity treatments. We explore glucagon, GIP, triple agonists, and emerging innovations shaping metabolic medicine. Listen now on all major platforms! "For decades, glucagon was viewed primarily as a hormone that raises blood glucose. Research later revealed that glucagon could also promote weight reduction and improve liver metabolism when balanced appropriately with GLP-1 activity." Meet the guest: Dr. Richard DiMarchi https://www.linkedin.com/in/richard-dimarchi-642a5710/ is a Distinguished Professor at Indiana University and a recognized leader in peptide therapeutics, diabetes research, and obesity medicine. His work contributed to major advances in insulin, glucagon, and multiagonist therapies, while also helping establish several biotechnology companies. Dr. DiMarchi continues to advance innovation in the treatment of metabolic diseases through research and translational science. Listen to Dr. Richard DiMarchi on The GLP-1 Podcast Show, available on all major platforms. What you will learn: Highlight Introduction GLP-1 evolution Multiagonist design Glucagon controversy GIP role Future treatments Final Questions 𝗟𝗶𝘀𝘁𝗲𝗻 𝗼𝗻 𝗔𝗽𝗽𝗹𝗲 𝗣𝗼𝗱𝗰𝗮𝘀𝘁𝘀, 𝗦𝗽𝗼𝘁𝗶𝗳𝘆 𝗼𝗿 𝗮𝗻𝘆 𝗺𝗮𝗷𝗼𝗿 𝗽𝗹𝗮𝘁𝗳𝗼𝗿𝗺. Website: https://www.wisenetix.com/glp1 Instagram: https://www.instagram.com/theglp1podcast/ LinkedIn: https://www.linkedin.com/showcase/the-glp-1-podcast-show/
Get The GLP-1 Podcast Show summaries in your inbox
Free AI-powered daily recaps. Key takeaways, quotes, and mentions — in a 5-minute read.
Get Free Summaries →Free forever for up to 3 podcasts. No credit card required.
You Might Also Like
Listeners also like.
The Holistic GLP-1 Podcast with Elizabeth McGann
Explores holistic approaches to GLP-1 for metabolic health, weight, and well-being through expert insights and natural strategies.
LONGEVITY with Nathalie Niddam
Explores science-backed strategies for extending healthspan through nutrition, biohacking, peptides, and emerging longevity research.
Diabetes Nerd
Discusses diabetes research, technology, management strategies, and personal stories through candid conversations.
Live Like a Girl with Dr. Mindy Pelz
Dr. Mindy Pelz explores women's health through hormone science and wellness conversations to help women live in rhythm with their bodies.
Made for Health | Peptides | Lyme | Chronic Infections | Long Covid | Insulin Resistance | Hypermobility
A physician explores science-based approaches to treating chronic conditions and restoring health.
Peak Performance Life Podcast
Covers health, energy, and mental performance optimization through biohacking, nutrition, and lifestyle strategies.
Get Better Faster
Doctors and researchers discuss functional medicine and root-cause approaches to chronic illness and health optimization.
The Hunter Williams Podcast
Explores cutting-edge science in peptides, hormone optimization, and biohacking with experts pushing the limits of human performance.
The Dr. Gabrielle Lyon Show
Discusses health, longevity, and mental resilience through science-based conversations with medical and wellness experts.
Extend Podcast with Darshan Shah, MD
Explores science-backed strategies and expert insights to extend healthspan and optimize longevity through actionable health protocols.
Sam Miller Science
Sam Miller
The Dr. Hyman Show
Explores root causes of chronic disease and promotes functional medicine, nutrition, and preventive health through expert discussions.
About The GLP-1 Podcast Show
A whole new era of communication in GLP-1 is here! Now you’ve got the sharpest minds in GLP-1 research right in your pocket. What’s best? You can listen to them while driving to the hospital, walking between labs, traveling, or just running errands. It’s never been this good or this simple. Welcome to The GLP-1 Podcast Show, a monthly podcast where you’ll hear cutting-edge perspectives and what’s working in the world of GLP-1. Our aspiration is to be the first place you are going to go to find out what's happening, the latest breakthroughs, clinical updates, and innovations in GLP-1 care and research.
Customized Recaps
AI-powered recaps with compact key takeaways, quotes, and insights.
Straight to Your Inbox
Get key takeaways from The GLP-1 Podcast Show in a 5-minute read.
Save Hours Every Week
Stay current on your favorite podcasts without falling behind.
Frequently Asked Questions
What is Podzilla's The GLP-1 Podcast Show daily summary?
It's a free AI-powered email that summarizes new episodes of The GLP-1 Podcast Show as soon as they're published. You get the key takeaways, notable quotes, and links & mentions — all in a quick read.
How does the The GLP-1 Podcast Show podcast summary work?
When a new episode drops, our AI transcribes and analyzes it, then generates a personalized summary tailored to your interests and profession. It's delivered to your inbox every morning.
Is this an official The GLP-1 Podcast Show product?
No. Podzilla is an independent service that summarizes publicly available podcast content. We're not affiliated with or endorsed by Wisenetix.
Can I get summaries of other podcasts too?
Absolutely! The free plan covers up to 3 podcasts, any in the catalog. Basic raises that to 15, Pro to 40 and Max to 100. Browse our full catalog at /podcasts.
How often does The GLP-1 Podcast Show release new episodes?
The GLP-1 Podcast Show publishes monthly. Our AI generates a summary within hours of each new episode.
What topics does The GLP-1 Podcast Show cover?
The GLP-1 Podcast Show covers topics including Medicine, Fitness, Health & Fitness. Our AI identifies the specific themes in each episode and highlights what matters most to you.
Start getting The GLP-1 Podcast Show summaries tomorrow morning.
Free forever for up to 3 podcasts. No credit card required.
Free forever for up to 3 podcasts. No credit card required.